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Skeletal muscle triglyceride levels are inversely related to insulin action
Abstract
In animal studies, increased amounts of triglyceride associated with skeletal muscle (mTG) correlate with
reduced skeletal muscle and whole body insulin action. The aim of this study was to test this relationship
in humans. Subjects were 38 nondiabetic male Pima Indians (mean age 28 ± 1 years). Insulin sensitivity
at physiological (M) and supraphysiological (MZ) insulin levels was assessed by the euglycemic clamp.
Lipid and carbohydrate oxidation were determined by indirect calorimetry before and during insulin
administration. mTG was determined in vastus lateralis muscles obtained by percutaneous biopsy.
Percentage of body fat (mean 29 ± 1%, range 14–44%) was measured by underwater weighing. In simple
regressions, negative relationships were found between mTG (mean 5.4 ± 0.3 μmol/g, range 1.3–1.9
μmol/g) and log10M (r = −0.53, P ≤ 0.001), MZ (r = −0.44, P = 0.006), and nonoxidative glucose disposal (r
= −0.48 and −0.47 at physiological and supraphysiological insulin levels, respectively, both P = 0.005) but
not glucose or lipid oxidation. mTG was not related to any measure of adiposity. In multiple regressions,
measures of insulin resistance (log10M, MZ, log10[fasting insulin]) were significantly related to mTG
independent of all measures of obesity (percentage of body fat, BMI, waist-to-thigh ratio). In turn, all
measures of obesity were related to the insulin resistance measures independent of mTG. The obesity
measures and mTG accounted for similar proportions of the variance in insulin resistance in these
relationships. The results suggest that in this human population, as in animal models, skeletal muscle
insulin sensitivity is strongly influenced by local supplies of triglycerides, as well as by remote depots and
circulating lipids. The mechanism(s) underlying the relationship between mTG and insulin action on
skeletal muscle glycogen synthesis may be central to an understanding of insulin resistance.
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Skeletal muscle triglyceride levels are inversely related to insulin action.
D.A. Pan, S. Lillioja, A.D. Kriketos, M.R. Milner, L.A. Baur, C. Bogardus, A.B.
Jenkins and L.H. Storlien.
Dapartment of Biomedical Science, University of Wollongong, and the Department of
Endocrinology, Royal Prince Alfred Hospital, Camperdown and the Clinical Diabetes and
Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix,
Arizona.
In animal studies, increased amounts of triglyceride associated with skeletal muscle (mTG)
correlate with reduced skeletal muscle and whole body insulin action. The aim of this study
was to test this relationship in humans. Subjects were 38 nondiabetic male Pima Indians (mean
age 28 [+ or -] 1 years). Insulin sensitivity at physiological (M) and supraphysiological (MZ)
insulin levels was assessed by the euglycemic clamp. Lipid and carbohydrate oxidation were
determined by indirect calorimetry before and during insulin administration. mTG was
determined in vastus lateralis muscles obtained by percutaneous biopsy. Percentage of body fat
(mean 29 [+ or -] 1%, range 14-44%) was measured by underwater weighing. In simple
regressions, negative relationships were found between mTG (mean 5.4 [+ or -] 0.3
[micro]mol/g, range 1.3-1.9 [micro]mol/g) and [log.sub.10]M (r = -0.53, P [less than or equal
to] 0.001), MZ (r = -0.44, P = 0.006), and nonoxidative glucose disposal (r = -0.48 and -0.47 at
physiological and supraphysiological insulin levels, respectively, both P = 0.005) but not
glucose or lipid oxidation, mTG was not related to any measure of adiposity. In multiple
regressions, measures of insulin resistance ([log.sub.10]M, MZ, [log.sub.10][fasting insulin])
were significantly related to mTG independent of all measures of obesity (percentage of body
fat, BMI, waist-to-thigh ratio). In turn, all measures of obesity were related to the insulin
resistance measures independent of mTG. The obesity measures and mTG accounted for
similar proportions of the variance in insulin resistance in these relationships. The results
suggest that in this human population, as in animal models, skeletal muscle insulin sensitivity
is strongly influenced by local supplies of triglycerides, as well as by remote depots and
circulating lipids. The mechanism(s) underlying the relationship between mTG and insulin
action on skeletal muscle glycogen synthesis may be central to an understanding of insulin
resistance. Diabetes 46:983-988, 1997
NIDDM, obesity, hypertension, dyslipidemias, and cardiovascular disease are all prevalent
diseases that have been linked with impaired insulin action (insulin resistance) (1). Skeletal
muscle has been identified as the primary site of insulin-stimulated glucose disposal at
euglycemia (2,3) and, as such, is a major locus of insulin resistance. However, the mechanisms
responsible for muscle insulin resistance remain unclear.
Increased circulation lipid supply has been shown to impair glucose metabolism through
effects on both glucose oxidation and storage (4-9). The corollary that decreasing lipid supply
will increase glucose metabolism has also received strong experimental support (10,11). These
studies have generally addressed circulating lipids; little information is available about the role
of stored muscle lipids.
Animal studies have shown that triglyceride associated with skeletal muscle (mTG) is an
important source of lipid for energy within muscle (12,13). In addition, there is evidence to
suggest that an intramuscular lipid pool may exist within human skeletal muscle as an

immediate source of energy (14). In studies in the high-fat-fed rat, increases in storage
triglyceride within single hindlimb muscles have been clearly associated with impairment in
insulin-stimulated glucose metabolism in those same muscles (15). No such studies are
available in humans. The aim of the present study was to examine the relationship between
mTG and measures of insulin action in humans.
RESEARCH DESIGN AND METHODS
The sample cohort was 38 male Pima Indian volunteers of the Gila River Indian Community
who were participating in a longitudinal study of the development of NIDDM (16). Subjects
had a mean age of 28 [+ or -] 1 years, height 171.1 [+ or -] 0.8 cm, and weight 95.8 [+ or -] 3.1
kg and were in good health as assessed by medical history and physical examination. All
subjects gave informed consent, and the studies were al)proved by the ethics committees of the
National Institutes of Health, the Indian Health Service, and the Gila River Indian Community.
All subjects were admitted to the Phoenix Clinical Research Unit of the National Institutes of
Health and stabilized for 2 days or more on a weight-maintenance diet (50% carbohydrate,
30% fat, and 20% protein). Glucose tolerance was assessed after administration of a 75-g oral
glucose load using World Health Organization criteria (17). Glucose tolerance was normal in
all subjects. Body composition (percent body fat) was estimated by hydrodensitometry with
simultaneous determination of lung residual volume (18,19).
Euglycemic-hyperinsulinemic clamp. In vivo insulin mediated glucose disposal rate weeks
measured by a two step euglycemic-hyperinsulinemic clamp (4). The clamp was performed by
primed continuous low- and high-dose insulin infusions (290 and 2,900 pmol x [min.sup.-1] x
[m.sup.-2], respectively), each of which was continued for 100 min while the plasma glucose
was maintained at ~5.5 mmol/l. In vivo insulin action was determined during the period from
60 to 100 min. During this time, plasma glucose uptake approached steady stale, but it is
unlikely that a precise steady state was achieved. Nevertheless, in these studies, because
comparisons are made between individuals and not the calculation of rates of glucose disposal
or hepatic glucose production, this is not critical. Plasma glucose was measured by the glucose
oxidase method using a glucose analyzer (Beckman Instruments, Fullerton, CA) and plasma
insulin by radioimmunoassay using a radioassay analyzer (Concept 4, ICN, Horsham, PA).
Indirect calorimetry. At 40 min before the initial insulin infusion and for the last 40 min during
each of the insulin infusions, oxygen consumption and carbon dioxide production were
determined by open-circuit indirect calorimetry (4). A transparent plastic hood was placed over
the subject's head and secured around the neck with a soft collar. The subjects were supine and
were asked to remain motionless and awake during the test. The flow rate was measured by
using a pneumotachograph attached to a Fleisch flow transducer (Gould, Cleveland, OH). A
constant fraction of the expired gases was withdrawn and analyzed for oxygen and carbon
dioxide concentrations. Oxygen was measured by a zirconium cell analyzer and carbon dioxide
by an infrared analyzer (Applied Electrochemistry, Sunnyvale, CA). The analyzers and
flowmeter outputs were connected to a desktop computer (Hewlett Packard, Palo Alto, CA),
which recorded continuous integrated calorimetric measurements over 5-min intervals. The
basal and insulin-stimulated carbohydrate oxidation and lipid oxidation rates were calculated
from indirect calorimetry data (20). Six subjects did not have indirect calorimetry determined.
Muscle biopsy. At 2 days after the euglycemic-hyperinsulinemic clamp, a percutaneous biopsy
of the vastus lateralis muscle was obtained. After a 12-h overnight fast, the skin and

suprafascial tissue of the thigh were anesthetized with 8-10 ml of 1% lidocaine HCl (Astra
Pharmaceutical Products, Westborough, MA), and the biopsy was performed with a Bergstrom
needle (Depuy, Phoenix, AZ). The specimen was immediately frozen and stored in liquid
nitrogen for later analysis.
Skeletal muscle triglyceride analysis. Extraction and isolation of the lipid components of
skeletal muscle have been described previously (21). in brief, muscle tissue was homogenized
in 2:1 (vol/vol) chloroform:methanol and total lipids extracted. Nonpolar lipids were isolated
by solid-phase extraction, and triglyceride content then was determined spectrophotometrically
at 500 nm by using an enzymatic colorimetric test kit, Triglycerides GPO-PAP (Boehringer
Mannheim, Sydney, Australia) and a Cary 3 spectrophotometer (Varian, Mulgrave, Australia).
Samples were quantitated against a standard curve of Precimat glycerol (Boehringer
Mannheim).
Calculations. Total glucose disposal (at physiological [M] and supraphysiological [MZ] levels)
was expressed as milligrams per minute per kilogram fat-free mass plus 17.7 based on the
regression relationship observed in a large sample from the same population as the study group
(20). Measures of glucose storage (at physiological [S] and supraphysiological [SZ] insulin
concentrations) were calculated from the difference between the raw glucose disposal measures
and carbohydrate oxidation measures and then expressed per kilogram of fat-free mass.
Statistics. All statistical analyses were performed using the Statview SE+ graphics package
(Abacus Concepts, Berkeley, CA). Relationships between variables were analyzed by simple
correlation and by multiple and stepwise linear regressions. The significance of simple
correlation coefficients was assessed using Fishers Z transformation. The significance of
independent relationships in the multiple and stepwise regressions were assessed by a t test on
the regression coefficients. Variables showing evidence of skewed distributions in larger
published data sets in Pima Indians were log-transformed before analysis (M and fasting
insulin). Stepwise regressions were performed in the forward direction with F for entry set to 4.
Data are presented as means [+ or -] SE.

RESULTS
Members of the study group were young but overweight (Table 1), with mean body fat of 29 [+
or -] 1% (range 18 to 44%). Other subject characteristics, including measures of insulin action
at M and MZ and basal and clamp carbohydrate/lipid oxidation values, are also listed in Table
1.
The mean value obtained for mTG in the skeletal muscles of the study group was 5.4 [+ or -]
0.3 [micro]mol/g wet wt, with a range of 1.3-9.8 [micro]mol/g wet wt. A direct relationship
was observed between mTG and the log fasting plasma insulin (LFPIns) values (r = 0.44, P <
0.006). A negative relationship was found between the insulin action at the low dose of the
euglycemic-hyperinsulinemic clamp and the triglyceride content (r = -0.53, P < 0.0006; Fig. 1).
A similar relationship was found between skeletal mTG and insulin action at the
supraphysiological insulin level (r = -0.44, P < 0.006).
Measures of adiposity as determined by percent body fat, BMI, and waist-to-thigh ratio (W/T;
as a measure of central adiposity) were significantly negatively related to insulin action
(percent body fat and M: r = -0.50, P < 0.001; BMI and M: r = -0.49, P < 0.002; W/T and M: r
= -0.49, P < 0.002). However, in contrast to the relationships observed between mTG and the
three measures of insulin action, no significant relationships were found between mTG and any
measure of adiposity (Table 1).
Tables 2 and 3 show all possible permutations of the independent relationships between mTG,
insulin action, and adiposity, mTG content was related to LFPIns, log M, and MZ independent
of percent body fat, BMI, and W/T. In turn, all three measures of adiposity were related to all
three measures of insulin action independent of mTG. However, adiposity and muscle
triglyceride were not significantly related to each other in any manner.
In a stepwise regression analysis of the various predictors of [log.sub.l0]M, only mTG (t =
4.12, P = 0.0002) and W/T (t = 3.19, P = 0.003) were identified as independent correlates, with
percent body fat and BMI not entering the regression. Together, mTG and W/T accounted for
44% of the variance in [log.sub.10]M (29% of MZ).
Both M (r = -0.51, P < 0.002) and MZ (r = -0.53, P < 0.001) were significantly negatively
correlated with the respective clamp lipid oxidation rates, mTG was not related to any measure
of lipid or carbohydrate oxidation either basally or during the low- or high-dose insulin
infusions.
mTG was significantly (P < 0.005) negatively related to S (r = -0.48) and SZ (r = -0.47), as
shown in Table 1. Also, significant relationships were found between percent body fat, BMI,
and W/T with S (r = -0.37, -0.39, and -0.36, respectively; all P < 0.05) but not with SZ (all P >
0.05). However, the relationship between mTG and glucose storage was independent of all
measures of adiposity.
DISCUSSION
An oversupply of lipid has been shown to lead to insulin resistance, whereas a reduction in
lipid or reduced lipid oxidation and availability increases insulin action (11,23-25). Much of
the experimental work has focused on circulating lipid supply. Infusions of triglyceride
previously have been shown to reduce insulin-stimulated nonoxidative glucose disposal (9,26),

whereas increased supply of free fatty acids is associated with reduced muscle glycogen
accumulation (7,27). However, the present findings suggest that lipids other than those
immediately available from the circulation may have major effects on insulin action. Even
more surprising is that these postulated lipid effects are not only independent of adiposity but
equally as powerful as the well-known effects of obesity on insulin action. Skeletal muscle
contains energetically significant quantities of triglyceride (28), and studies in animals have
shown that its content is negatively related to insulin action (15). The present study has
provided strong support for a significant role of mTG in humans as a source of lipid to impair
insulin-mediated glucose metabolism in muscle, in particular the nonoxidative component.
Earlier work in animals (15) showed modulation of mTG by high-fat diets (59% of total
calories as fat) with varying fatty acid profiles. Insulin action was directly assessed within
individual tissues and triglyceride content determined within that same tissue. This current
study assessed insulin action, via three different measures, at the whole body level, whereas
triglyceride content was determined in a single muscle. Despite these methodological
differences, a significant negative relationship between insulin action and skeletal muscle
triglyceride content was again observed. This highlights the importance of skeletal muscle
triglyceride content as a major variable in insulin-mediated glucose disposal in the body. These
results alone cannot demonstrate either the existence or direction of causality. Equally, the
Pima Indians are a particularly diabetes-prone group, and the present results require
confirmation in other more insulin-sensitive populations. However, in conjunction with the
animal studies where dietary (15) or pharmaceutical (25) manipulation of muscle triglyceride
levels consistently alters insulin action in the predicted direction, they suggest that mTG may
be a contributing cause of insulin resistance.

Until now, circulating lipid has been considered the major lipid influence on glucose
metabolism. However, clearly skeletal mTG represents another important factor. This point is

emphasized by the lack of relationship between measures of whole body adiposity and mTG.
In keeping with this, Groop et al. (30) have demonstrated that increasing insulin levels in obese
individuals resulted in a similar decline in plasma free fatty acid oxidation to that in lean
individuals. However, inhibition of total lipid oxidation (circulating and endogenous) was less
sensitive to insulin in the obese, apparently due to a relative failure to suppress endogenous
muscle lipolysis. Furthermore, insulin resistance has been linked with an indirect index of
elevated lipid in muscle (reduced Hounsfield attenuation on computed tomography scans [31]).
This latter study showed a strong negative correlation between glucose storage and this
measure of increased muscle fat, findings consistent with the present results. These workers
also found--again in line with the findings of this study--that measures of muscle fat and
visceral obesity were independent predictors of insulin resistance. Moreover, stepwise
regression revealed that an increased measure of muscle fat had the strongest predictive value
for insulin resistance and together with visceral fat content accounted for 57% of the variance
in glucose storage in the leg muscle that they analyzed. The parallels between these two sets of
findings emphasize the dual but independent importance of mTG and visceral adiposity,
possibly contributing through the influence on circulating lipids, in insulin-mediated glucose
uptake.

The amount of triglyceride in muscle found here is energetically significant. If fully oxidized
for energy, it would provide ~50% of the energy potentially available from the glycogen levels
reported in a similar group of Pima Indians (32). The only other study of insulin-resistant
subjects found that triglyceride associated with rectus abdominis muscle biopsies obtained
during surgery ranged from ~40 to 600 [micro]mol/g wet wt (5). These extraordinarily high
values were most likely due to contamination from adipose depots. In keeping with the
findings in this paper, other studies that have measured mTG yielded values of <50

[micro]mol/g tissue (33-36). The skeletal muscle biopsies obtained in this study were from
deep within the vastus lateralis and free of any visible signs of contamination from
subcutaneous or other adipose depot stores. Thus, while the triglyceride was not localized to
within the muscle fibers, early evidence suggests that it is (28); that is consistent with the
excellent relation with insulin action independent of total body adiposity, which should relate
more closely to intermuscle fat. However, it must be emphasized that we have not localized the
lipid, and this is a matter of importance for further work.

With regard to this latter point, trained athletes and animals show the same or higher levels of
muscle triglycerides as sedentary controls (33-35,37) but have improved insulin action (38,39).
This is unexpected in light of the relationship exposed in the current investigation, and the
question is why do higher levels of triglyceride in trained individuals not lead to insulin
resistance? The answer may lie in the distribution of that triglyceride. Endurance exercise
increases both the mitochondrial volume and distribution in skeletal muscle (40). In addition,
recent electron microscopy studies have revealed that in trained dogs, mitochondria appear
virtually in direct contact with triglyceride droplets (37), in contrast with the lack of association
with mitochondria in untrained animals. That may account both for the improved ability of
trained individuals to mobilize fat for energy during moderate-intensity exercise and for the
lack of a detrimental effect of such storage lipid on glucose metabolism. In contrast, in
sedentary individuals the lipid may be located within neutral lipid domains of the plasma
membrane itself (41,42), which may then affect second-messenger systems (43). Localization
of lipid in one or more membranes may affect translocation of glucose transporters (44) or
insulin receptor tyrosine kinase activity (45,46). Electron microscopy localization studies in
sedentary and trained individuals would be instructive in this regard.
Recently, we have shown in Pima Indians that the fatty acid profile of the major muscle
membrane lipid (phospholipid) was closely linked to insulin action such that a higher
proportion of saturated fats was associated with insulin resistance (47). In this subset of that
study group, mTG was negatively related to the phospholipid unsaturation index (r = -0.323, P
< 0.05; data not shown), such that the greater the proportion of unsaturated phospholipid fatty
acids, the lower the stored skeletal muscle triglyceride. The mechanisms involved in this
relationship are not proven, but it is consistent with the notion that saturated fats reduce the
energy requirements of the cell due to reduced ion permeability (48,49), thereby tipping the
balance away from lipid utilization for energy and toward storage.
In summary, this study finds a significant negative relationship between muscle triglyceride
content and nonoxidative glucose disposal in humans, concordant with and extending previous
findings in rats. This relationship is independent of measures of total and central adiposity.

Although the mechanisms responsible for this relationship are unclear, they may be central to
an understanding of the link between lipid metabolism and insulin resistance.
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LFPIns, log fasting plasma insulin; M and MZ, h)w-dose (physiological) and high-dose
(supraphysiological) in vivo insulin-mediated glucose disposal rates, respectively; mTG,

triglyceride associated with skeletal muscle; S and SZ, nonoxidative components of total
glucose disposal at physiological and supraphysiological insulin concentrations, respectively;
W/T, waist-to-thigh ratio.
TABLE 1
Mean values and ranges of anthropometric and metabolic variable and
simple correlations with skeletal muscle associated triglyceride
concentration (mTG)
n
BMI (kg/[m.sup.2])
Percentage body fat
Waist/thigh
Fasting plasma glucose (mmol/1)
Fasting plasma insulin (pmol/1)
Total M ([mg x [min.sup.-1] x
kg FF[M.sup.-1] + 17.7)
Total MZ ([mg x [min.sup.-1] x
kg FF[M.sup.-1] + 17.7)
Basal oxidation (mg x
[min.sup.-1] x kg FF[M.sup.-1])
Carbohydrate
Lipid
M oxidation (mg x [min.sup.-1] x
kg FF[M.sup.-1])
Carbohydrate
Lipid
MZ oxidation (mg x [min.sup.-1] x
kg FF[M.sup.-1])
Carbohydrate
Lipid
S (glucose storage component of M)
SZ (glucose storage
component of MZ)

38
38
38
38
38
38
38
32

32

32

32
32
Value

BMI (kg/[m.sup.2])
Percentage body fat
Waist/thigh
Fasting plasma glucose (mmol/1)
Fasting plasma insulin (pmol/1)
Total M ([mg x [min.sup.-1] x
kg FF[M.sup.-1] + 17.7)
Total MZ ([mg x [min.sup.-1] x
kg FF[M.sup.-1] + 17.7)
Basal oxidation (mg x
[min.sup.-1] x kg FF[M.sup.-1])
Carbohydrate
Lipid
M oxidation (mg x [min.sup.-1] x
kg FF[M.sup.-1])
Carbohydrate
Lipid
MZ oxidation (mg x [min.sup.-1] x
kg FF[M.sup.-1])
Carbohydrate
Lipid

32.7
29
1.6
5.0
220
3.2

[+
[+
[+
[+
[+
[+

or
or
or
or
or
or

-]
-]
-]
-]
-]
-]

1.1 (19.0-52)
1 (18-44)
0.1 (1.3-2.2)
0.1 (4.1-6.0)
17 (85-677)
0.2 (1.6-7.2)

8.8 [+ or -] 0.3 (3.9-13.4)

1.64 [+ or -] 0.09 (0.70-3.10)
0.58 [+ or -] 0.04 (0.14-0.93)

2.27 [+ or -] 0.09 (1.31-3.50)
0.32 [+ or -] 0.04 (-0.36-0.73)

3.40 [+ or -] 0.10 (2.34-4.69)
-0.02 [+ or -] 0.04 (-0.47-0.38)

S (glucose storage component of M)
SZ (glucose storage
component of MZ)

0.93 [+ or -] 0.22 (-0.68-4.47)
5.36 [+ or -] 0.31 (0.57-9.57)
r

BMI (kg/[m.sup.2])
Percentage body fat
Waist/thigh
Fasting plasma glucose (mmol/1)
Fasting plasma insulin (pmol/1)
Total M ([mg x [min.sup.-1] x
kg FF[M.sup.-1] + 17.7)
Total MZ ([mg x [min.sup.-1] x
kg FF[M.sup.-1] + 17.7)
Basal oxidation (mg x
[min.sup.-1] x kg FF[M.sup.-1])
Carbohydrate
Lipid
M oxidation (mg x [min.sup.-1] x
kg FF[M.sup.-1])
Carbohydrate
Lipid
MZ oxidation (mg x [min.sup.-1] x
kg FF[M.sup.-1])
Carbohydrate
Lipid
S (glucose storage component of M)
SZ (glucose storage
component of MZ)

0.175
0.232
0.026
0.100
0.435
-0.531
-0.438

0.035
0.225

0.202
0.265

0.192
0.256
-0.475
-0.474
p *

BMI (kg/[m.sup.2])
Percentage body fat
Waist/thigh
Fasting plasma glucose (mmol/1)
Fasting plasma insulin (pmol/1)
Total M ([mg x [min.sup.-1] x
kg FF[M.sup.-1] + 17.7)
Total MZ ([mg x [min.sup.-1] x
kg FF[M.sup.-1] + 17.7)
Basal oxidation (mg x
[min.sup.-1] x kg FF[M.sup.-1])
Carbohydrate
Lipid
M oxidation (mg x [min.sup.-1] x
kg FF[M.sup.-1])
Carbohydrate
Lipid
MZ oxidation (mg x [min.sup.-1] x
kg FF[M.sup.-1])
Carbohydrate
Lipid
S (glucose storage component of M)
SZ (glucose storage
component of MZ)

0.3
0.2
0.9
0.6
0.006
0.001
0.006

0.8
0.2

0.3
0.1

0.3
0.2
0.005
0.005

Data are n or means [+ or -] SE (range), unless otherwise indicated.
FFM, fat-free mass. r values were determined by simple regression
against mTG. Regression against mTG was performed with the [log.sub.10]

of fasting plasma insulin and total M values. * Significance level
associated with r.
TABLE 2
Multiple regression results for the equation x2
y = [a.sub.o] + [a.sub.l] [x.sub.l] + [a.sub.2]
mTG=y
Independent variables

t

P

% fat
LFPIns

0.037
2.421

<0.97
<0.02

BMI
LFPIns

0.254
2.636

<0.80
<0.01

W/T
LFPIns

1.318
3.210

<0.20
<0.003

% fat
LogM

0.242
3.340

<0.81
<0.002

BMI
LogM

0.671
3.582

<0.51
<0.001

W/T
Loges

1.546
4.123

<0.13
<0.0002

% fat
MZ

0.669
2.544

<0.51
<0.02

BMI
MZ

0.305
2.660

<0.76
<0.01

W/T
MZ

0.844
3.023

<0.40
<0.005

t and P, significance of coefficients for [x.sub.l] and [x.sub.2]
(i.e., independent effects as predictors); % fat, percent body fat.
TABLE 3
Multiple regression results for the equation y = [a.sub.o] + [a.sub.l]
[x.sub.l] + [a.sub.2] [x.sub.2]
Independent
variables

t

LFPIns = y
P

% fat
mTG

3.246
2.421

<0.003
<0.02

2.985
3.340

<0.005
<0.002

BMI
mTG

3.022
2.636

<0.005
<0.01

3.167
3.582

<0.003
<0.001

W/T
mTG

3.394
3.210

<0.002
<0.003

3.194
4.123

<0.003
<0.0002

Independent
variables

t

MZ = y
P

t

LogM = y
P

% fat
mTG

1.462
2.544

<0.15
<0.016

BMI
mTG

1.533
2.660

<0.13
<0.01

W/T
mTG

2.269
3.023

<0.03
<0.005

t and P, significance of coefficients for [x.sub.1] and [x.sub.2]
(i.e., independent effects as predictors); % fat, percent body fat.

